Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 26, 2004

View Archived Issues

Ferring acquires Dupomar

New adenoviral vector for cystic fibrosis gene therapy identified

Genentech reports R&D highlights

Evotec OAI enters into medicinal chemistry collaboration

Menarini presents new bradykinin B2 antagonists for inflammatory and allergic disorders

Schering AG claims novel SERM for infertility, menopausal complaints, etc.

New 11beta-HSD1 inhibitors for diabetes, obesity, etc. covered by Merck patent

Memantine reported to enhance the beneficial effects of donepezil in moderate to severe AD

Novel caspase 1 inhibitors identified by Sunesis researchers

GSK presents another series of antibacterial PDF inhibitors

Dose-dependent improvements found with solifenacin in urinary incontinence

New histamine H3 antagonists prepared and tested by Schering-Plough team

Lilly scientists design new prodrugs of mGluR2 agonists

Albendazole reported effective in reducing seizures in patients with neurocysticercosis

New MRI agents for the diagnosis of tumors designed at Bracco

Update on Ushercell and Usherdex-4

Fast track designation for VaxGen's rPA-102

Zevalin radioimmunotherapy receives European approval

Approval for generic metoprolol tartrate

Micrologix Biotech discusses regulatory path for MBI-226 with FDA

Moscow sites open in phase II Liprostin trial

Onyvax and Mayo Clinic to develop cancer vaccines for ovarian cancer

SGN-30 enters new phase II study

German bone graft study commences for Aastrom's TRCs

XMP-629 enters phase II for acne

Enrollment completed in phase I Psoraxine trial

European approval for Mononine continuous intravenous infusion

Quigley Pharma provides update on research activities

Metabolex announces extension of collaboration focused on insulin secretion defects in diabetes

Neurochem forms alliances for its Alzheimer's disease synthetic vaccine program

Therapeutic benefits of cinacalcet in primary hyperparathyroidism

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...